HRA Pharma creates innovative medicines and products for women's and reproductive health, endocrine diseases and cell therapies.

English Deutsch Español Italiano

HRA Pharma creates
innovative products
to fill therapeutic gaps
in reproductive health
and endocrinology.

February 27, 2012
Paris, France

Ulipristal Acetate Granted European Marketing Authorisation for the treatment of symptoms of Uterine Fibroids
April 2, 2012
Paris, France

ellaOne® emergency contraceptive launched in Italy by HRA Pharma